Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015

Journal of the European Academy of Dermatology and Venereology - Tập 28 Số 9 - Trang 1170-1178 - 2014
Melina Arnold1, Cynthia Holterhues2, Loes M. Hollestein2, J.W.W. Coebergh3,1, Tamar Nijsten2, ­Eero Pukkala4,5, Bernd Holleczek6, Laufey Tryggvadóttír7,8, Harry Comber9, María José Bento10, Ch.S. Diba11, R. Micallef12, Maja Primic‐Žakelj13, M. Isabel Izarzugaza14, Josefina Perucha15, Rafael Marcos‐Gragera16, Jaume Galcerán17, Eva Ardanáz18,19, Robin Schaffar20, Andrew Pring21, Esther de Vries3,2,1
1Department of Public Health, ErasmusMC University Medical Center Rotterdam, The Netherlands
2Department of Dermatology, ErasmusMC University Medical Center Rotterdam, The Netherlands
3Comprehensive Cancer Center South, Eindhoven, The Netherlands
4Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
5School of Health Sciences, University of Tampere, Tampere, Finland
6Saarland Cancer Registry, Saarbrücken, Germany
7Faculty of Medicine, University of Iceland, Reykjavik, Iceland
8Icelandic Cancer Registry, Reykjavik, Iceland
9National Cancer Registry, Cork, Ireland
10North Region Cancer Registry, Portuguese Oncology Institute, Porto, Portugal
11National Cancer Registry of Slovakia, National Health Information Center, Bratislava, Slovakia
12Department of Health Information and Research, Malta National Cancer Registry, Guardamangia, Malta
13Epidemiology and Cancer Registry, Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia
14Basque Goverment Health Department, Basque Cancer Registry, Vitoria-Gasteiz, Spain
15Servicio de Epidemiología y Prevención Sanitaria Registro de Cáncer de La Rioja Logroño Spain
16Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), Girona, Spain
17Tarragona Cancer Registry. Foundation Society for Cancer research and Prevention, Pere Virgili Health Research Institute, Reus, Spain
18CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain
19Navarra Cancer Registry, Navarra Public Health Institute, Pamplona, Spain
20Geneva Cancer Registry, Institute for Social and Preventive Medicine, University of Geneva, Geneva, Switzerland
21Public Health England, Bristol, United Kingdom

Tóm tắt

AbstractBackgroundMelanoma is a significant health problem in Caucasian populations. The most recently available data from cancer registries often have a delay of several months up to a few years and they are generally not easily accessible.ObjectivesTo assess recent age‐ and sex‐specific trends in melanoma incidence and make predictions for 2010 and 2015.MethodsA retrospective registry‐based analysis was performed with data from 29 European cancer registries. Most of them had data available from 1990 up to 2006/7. World‐standardized incidence rates (WSR) and the estimated annual percentage change (EAPC) were computed. Predictions were based on linear projection models.ResultsOverall the incidence of melanoma is rapidly rising and will continue to do so. The incidence among women in Europe was generally higher than in men. The highest incidence rates were seen for Northern and north‐western countries like the UK, Ireland and the Netherlands. The lowest incidence rates were observed in Portugal and Spain. The incidence overall remained stable in Norway, where, amongst young (25–49 years) Norwegian males rates significantly decreased (EAPC −2.8, 95% CI −3.6; −2.0). Despite a low melanoma incidence among persons above the age of 70, this age group experienced the greatest increase in risk during the study period.ConclusionsIncidence rates of melanoma are expected to continue rising. These trends are worrying in terms of disease burden, particularly in eastern European countries.

Từ khóa


Tài liệu tham khảo

10.1056/NEJMra052166

10.1038/jid.2010.58

10.1016/j.ejca.2007.12.015

10.1002/ijc.11360

10.1002/ijc.27616

10.1111/j.1365-2133.2012.11125.x

10.1016/j.ejca.2005.03.034

10.1016/j.ejca.2004.10.016

10.1016/j.ejca.2004.10.015

Parkin DM, 1992, Cancer Incidence in Five Continents. Comparability and quality of data, IARC Sci Publ, 120, 45

Parkin DM, 1992, Cancer incidence in five continents

10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z

10.1002/1097-0258(20000715)19:13<1741::AID-SIM496>3.0.CO;2-O

10.1002/(SICI)1097-0258(19971030)16:20<2297::AID-SIM668>3.0.CO;2-F

Association of the Nordic Cancer Registries. Danish Cancer Society.NORDCAN: Cancer Incidence Mortality Prevalence and Survival in the Nordic Countries Version 5.2(December 2012) [database on the Internet].2012. URLhttp://www.dep.iarc.fr/nordcan.htm. (last accessed: 06 February 2013).

Integraal Kankercentrum Nederland.Cijfers over kanker. [database on the Internet]2013. URLwww.cijfersoverkanker.nl.

10.1016/j.ejca.2012.12.027

10.1016/j.ejca.2012.11.030

10.1093/annonc/mdn639

10.1016/j.ejca.2009.12.014

10.1002/ijc.25516

10.1002/(SICI)1097-0215(19990331)81:1<62::AID-IJC12>3.0.CO;2-2

10.1093/annonc/mdr128

10.1016/j.ad.2009.05.001

10.1016/j.jphotobiol.2010.04.002

10.1097/01.cej.0000220634.31223.f7

10.1016/j.ejca.2004.06.003

10.1111/j.1365-2133.2011.10361.x

10.1111/j.1468-3083.2011.04162.x

10.1002/ijc.21836

10.1111/j.1468-3083.2010.03602.x

10.1111/j.1365-2133.2003.05554.x

10.1038/bjc.2012.22

10.1111/j.1365-2133.2012.11087.x

10.1016/j.jaad.2010.11.016